Enproject Medicali

Marsciano, Italy Founded: 2016 • Age: 10 yrs
Medical devices for hospital infection prevention are supplied.

About Enproject Medicali

Enproject Medicali is a Healthcare company based in Marsciano (Italy) founded in 2016. Medical devices for hospital infection prevention are supplied. Its chief executive, as recorded, is Umbro Sciamannini. Enproject Medicali offers products and services including ABT 9000, ABT 3000, ABT 6000, Axi-pure, and Axivirium Bioactive. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infection Control and Surface Sanitization. Its legal entity is ENPROJECT MEDICALI Srl.

Company details

Enproject Medicali was established in 2016 in Marsciano, Italy, within the medical devices sector. Devices aimed at preventing nosocomial infections from viruses and bacteria are offered, including liquid aspirators, surface disinfection units, and LED light disinfectors. Chemical and biological risks in healthcare settings are addressed through these products, with operations focused on infection control solutions.

  • Headquarters Marsciano, Italy
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website enprojectmedicali.com/en
  • Social LinkedIn
  • Legal Name Enproject Medicali Srl
Key Metrics
  • Latest Funding Round
    $55.73K (USD), Grant

    Jul 2019

  • Investors

Products & Services of Enproject Medicali

Enproject Medicali offers a comprehensive portfolio of products and services, including ABT 9000, ABT 3000, ABT 6000, Axi-pure, and Axivirium Bioactive.

ABT 9000
Biomedical Device

Aspirates and treats biological waste in hospitals with multiple suctions.

ABT 3000
Biomedical Device

Handles aspiration of chemical and biological waste efficiently.

ABT 6000
Biomedical Device

Modular device for treating large volumes of biological fluids.

Axi-pure
Disinfectant Solution

Chemical solution for managing infectious events in medical environments.

Axivirium Bioactive
Consumable Product

Blocks nuclease activity to prevent biological risks quickly.

Funding Insights of Enproject Medicali

  • Total Rounds 2
  • Last Round Grant β€” $55,732
  • First Round $57,280

    (Feb 2019)

  • Investors Count 2

All 2 funding rounds of Enproject Medicali with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2019$55,732Grant––
Feb 2019$57,280Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Enproject Medicali

Enproject Medicali has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for Enproject Medicali

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Enproject Medicali

1 people are tracked at Enproject Medicali (1 in leadership).

NameRoleGroup
Umbro Sciamannini
CEOLeadership
Premium access

Complete people profiles for Enproject Medicali

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Enproject Medicali

3 dated milestones of Enproject Medicali across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Enproject Medicali is founded.
  2. Funding First funding round of $57K.
  3. Funding Latest funding round, Grant, of $56K.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Enproject Medicali

Enproject Medicali was founded in 2016 and raised its 1st funding round 3 years after it was founded.

Enproject Medicali is headquartered in Marsciano, Italy. It is registered at Marsciano, Umbria, Italy.

Umbro Sciamannini is the CEO of Enproject Medicali, as recorded in our data.

Enproject Medicali was established in 2016 in Marsciano, Italy, within the medical devices sector. Devices aimed at preventing nosocomial infections from viruses and bacteria are offered, including liquid aspirators, surface disinfection units, and LED light disinfectors. Chemical and biological risks in healthcare settings are addressed through these products, with operations focused on infection control solutions.

Enproject Medicali offers ABT 9000, ABT 3000, ABT 6000, Axi-pure, and Axivirium Bioactive.

Enproject Medicali has 2 investors. Key investors include European Union, and EIC Fund.

Enproject Medicali operates through Enproject Medicali Srl.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available